News >
13/08/2007 - 17:05

pSivida completes recruitment stage of BrachySil trials

By Edited announcement
13/08/2007 - 17:05
Share to

Bookmark

Save articles for future reference.
Subscribe to BN Log In

Perth-headquartered bio-nanotech company pSivida Ltd has completed the recruitment stage of the second phase of a clinical study of cancer treatment technology BrachySil in the treatment of inoperable pancreatic cancer.

X

To read our articles you will need to either login or subscribe.